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Introduction

Methods and Materials
Helsinki. All participants provided written informed consent prior to participation in this study. 146 This study was part of a larger research expedition conducted between September and November 147 2016. As such, participants took part in a number of studies conducted at the University of 148 British Columbia (Kelowna, British Columbia; 344m) and during three weeks at the Ev-K2 CNR 149 pyramid laboratory (Khumbu Valley, Nepal, 5050m) . However, the a priori, primary research 150 questions addressed in the current paper are novel and are exclusively dealt within this study 151 alone.
153
Participants. Recruited participants (n=15; 1F) were normotensive (systolic blood pressure <140 154 and diastolic pressure <90 mmHg) at rest, and completed a medical history questionnaire. The 155 participants were non-smokers, had no previous history of cardiovascular, cerebrovascular, or 156 respiratory diseases. During the time of testing, one participant was taking oral contraceptives CNR research facility within two days of each other, after following a similar ascent profile (7-8 167 day trek) as described in detail elsewhere (17, 35, 55) . Upon ascent, all participants avoided 168 taking oral acetazolamide (i.e. Diamox), a carbonic anhydrase inhibitor commonly used to 169 prevent/treat high-altitude illness. Experimentation occurred between days 11 and 14 at high- 170 altitude, and no participants had any symptoms of altitude illness during the time of testing, nor 171 were any using aspirin, non-steroidal anti-inflammatory drugs, and phosphodiesterase-5 172 inhibitors. Experimental Design. 175 This study was conducted in two parts: sea-level and high-altitude investigations. Prior to each 176 experiment, all participants abstained from exercise, alcohol, and caffeine for at least 12 hours. 177 Additionally, participants were asked to consume a light meal at least four-hours prior to 178 experimentation, and to keep their diet consistent between experimentation days. In order to 179 determine whether our participants had normal healthy lung function, at sea-level we conducted 180 a forced vital capacity (FVC) test to measure lung function, a vital capacity and inspiratory 181 capacity maneuver to measure lung volumes, and a single breath carbon monoxide test to 182 quantify diffusing capacity on each individual. All testing procedures were conducted in 183 accordance with the American Thoracic Society and European Respiratory Society's joint 184 guidelines (36, 39) . For each of these tests, participants sat within a body plethysmography box 185 (V6200, Vmax Sensormedics, Yorba Linda, CA, USA) with a rigid upright posture and their feet 186 flat on the ground, whilst breathing through a spirometer and bacteriological filter while wearing 187 a nose-clip. All pulmonary function measurements were compared against population-based 188 predictions.
Experimental protocol. After becoming comfortable within our custom lower-body differential 191 pressure chamber (described below), participants were instructed to lie motionless in the supine 192 position and breathe normally for 20-minutes to ensure that blood volume was comparably 193 distributed prior to experimentation (21). At sea-level, muscle sympathetic nervous activity 194 (MSNA) in the radial nerve was collected in a subset of participants (attempted: n=10; obtained: 195 n=5) during the LBNP/LBPP protocol. Muscle SNA signals were obtained once the participant 196 was instrumented while laying supine in our custom lower-body differential pressure chamber 197 (described below). At sea-level and high-altitude, the protocol began with a five-minute eupneic 198 breathing baseline period, after which, the pressure within the chamber was altered to one of the 199 following: 1) -10 mmHg (LBNP trial), 2) remained unchanged at zero mmHg (control trial), or 200 3) +10 mmHg (LBPP trial). Once adequate pressure was achieved in the lower-body differential 201 chamber, the participant was asked to remain quiet and relaxed, and after five-minutes a brachial 202 artery FMD was performed on the participants left arm. Once the brachial artery FMD 203 measurement was collected, the pressure of the lower-body differential pressure chamber was 204 alleviated and the participant was given a five-minute recovery period. The protocol was then 205 repeated for the remaining two randomized conditions (i.e. LBNP, control, or LBPP). Before 206 each condition, a five-minute quiet resting baseline was endured (Refer to figure 1 for a 207 schematic of the protocol described above). 208 Additionally, out of the five participants that we were able to obtain radial MSNA data at 209 sea-level, MSNA signals were obtained in the peroneal nerve at rest at high-altitude in four of 210 these participants in order to demonstrate the effects of altitude on resting MSNA. Previous work has shown that there are no regional differences in MSNA between the radial and peroneal nerve 212 (42). FMD in the following published investigations (51-53)], whom has a between day coefficient of variation in FMD of 8.3 ± 2.1% (n=10, unpublished data). Following optimal image acquisition, 235 and one-minute of baseline recordings, the forearm was occluded by inflating the cuff to 220 236 mmHg for five-minutes. Recordings of diameter and velocity resumed 30-seconds prior to cuff 237 deflation and continuously for three-minutes thereafter (48). observed. Confirmation that the recorded signal represented MSNA was determined by the absence of skin paresthesias and a signal that increased in response to voluntary apnea but not 258 during arousal to a loud noise. Muscle sympathetic nervous activity was amplified 1,000× 259 through a preamplifier and 100× by a variable-gain, isolated amplifier. The amplified, raw 260 MSNA signal was band-pass filtered at a bandwidth of 700-2,000 Hz, sampled at 10,000 Hz and 261 stored for offline analysis (LabChart V7.1, ADInstruments, Colorado Springs, CO, USA). calculated as the percent increase in vessel diameter from resting baseline diameter to peak 272 diameter following cuff release, where baseline and peak diameters were automatically detected 273 from the continuous data described above.
274
Muscle sympathetic nervous activity was analyzed using peak analysis software 275 (LabChart V7.1, ADInstruments, Colorado Springs, CO, USA). Two minutes of MSNA data was 276 averaged immediately prior to the end of each LBNP, control, and LBPP trial, and was expressed 277 as the frequency of MSNA bursts per minute, and incidence per 100 heart beats. variable. This approach has been used to account for any changes in FMD that may be related to 285 differences in baseline diameter or shear rate between conditions (i.e. time and condition) (2). Effect of high-altitude on endothelial function 397 The effects of high-altitude acclimatization on endothelial function, as assessed via brachial 398 FMD, has been studied previously. These studies have reported contradictory results such as 399 reduced FMD (3, 35), or no change in FMD upon acclimatization to high-altitude (5, 6, 52, 53) .
400
Despite the disparities between these studies, elevations in SNA is proposed to have a profound 401 effect on brachial FMD (26, 53). After four-weeks of acclimatization to high-altitude (5260m),
402
MSNA has been shown to be elevated by ~200% (23). The current study confirms these previous 403 findings as we have demonstrated in four participants that MSNA was substantially elevated at 404 rest after acclimatization to 5050m (see figure 4 ). This increase in SNA and total peripheral 405 resistance is likely responsible for the substantial decrease in brachial artery blood flow observed 406 at high-altitude (14).
407
An alternative explanation for the reported differences between these high-altitude FMD 408 studies may lie within the mode of travel to high-altitude, and the severity of altitude exposure. 
Altering sympathetic nervous activity non-invasively with lower-body negative and lower-body
419 positive pressure. 420 There have been several investigations on the role of the SNA on endothelial function assessed 421 by brachial FMD at sea-level (1, 16, 26, 47, 53) ; however, none of these studies have 422 concurrently measured SNA using microneurography. Existing literature indicates that our mode 423 of altering SNA (i.e. mild LBNP and LBPP) could provide a useful model to evaluate the role of 424 SNA on endothelial function, assuming that this methodology significantly alters SNA 425 independent of hemodynamics (9, 18, 38, (41) (42) (43) . For the current project we developed a novel, 426 light-weight, purpose built lower-body differential pressure chamber and measured its 427 effectiveness of altering radial MSNA, which is representative of global MSNA (42), during our 428 sea level trial (n=5). Our radial MSNA data indicates that SNA was elevated during LBNP and 429 reduced during LBPP (see figure 3) . Here, we established an effective methodological approach, Effect of sympathetic nervous activity on endothelial function at sea-level. 440 Although there have been several reports of SNA influencing endothelial function (1, 16, 26, 48, 441 53), it has been suggested that the method of altering SNA may yield different results (16). For by using a local heating stimulus (to one arm) during LBNP in order to abolish the increase in 456 retrograde shear stress typically observed during moderate-to-severe magnitudes of LBNP (41, 47) . Their findings revealed that brachial artery endothelial function was restored after the heat 458 stimulus was applied and retrograde shear rate was reduced (47). However, altered 459 hemodynamics (e.g. increased heart rate and reduced stroke volume) during LBNP were still 460 present (47), and these physiological changes can directly affect endothelial function [reviewed 461 in (22)].
462
The current study attempts to address this research question by manipulating SNA largely 463 independent of changes in hemodynamics. This is the first study to investigate the role of SNA 464 on endothelial function by increasing and decreasing SNA using LBNP and LBPP, respectively, 465 findings confirmed (at sea-level) via microneurography. In contrast to our hypothesis, we did not 466 observe any change in brachial artery endothelial function during LBNP -a finding that is 467 consistent with at least one previous study (16), but opposes other reports (26, 47) . It is possible 468 that we did not increase SNA activity enough in order to influence endothelial function; 469 however, the experimental design may be more important than the magnitude of SNA increase.
470
For example, Dyson et al. (16) demonstrated that the only intervention that altered endothelial 471 function during elevated SNA was not the intervention that evoked the largest SNA response.
472
Interestingly, acute hypoxia (F I O 2 = 0.11) has shown to reduce brachial artery endothelial 473 function after 60-minutes (35), and this severity of hypoxia has been shown to increase SNA to 474 approximately the same extent as our -10 mmHg LBNP stimulus (13). Additionally, it is possible 475 that the current experimental design was too short in duration to evoke a change in vascular 476 resistance and endothelial function. For example, a recent study demonstrated that 30-minutes of 477 sustained moderate exercise reduced endothelial function via an α 1 -adrenergic pathway; 478 however, a ~10-minute maximal exercise test did not evoke the same results (53). Nevertheless, our data indicates that acute and mild SNA activation and deactivation via LBNP and LBPP does Methodological considerations 504 The degree of LBPP chosen for the current research project (i.e. +10 mmHg) was determined 505 based on previous literature, which reported no changes of MAP (18, 38) . However, during our 506 LBPP trials at sea-level and high-altitude, LBPP elevated MAP elevated by ~4-5 mmHg, 507 potentially due to LBPP associated transient fluid shifts. This result was likely not due to 508 measurement drift from our continuous blood pressure monitor (i.e. finometer), since LBPP 509 selectively increased MAP in both sea-level and high-altitude protocols, and the finometer was 510 carefully calibrated before each trail. Changes in blood pressure could have a direct effect on 511 brachial FMD (22); however, since mild LBNP and LBPP did not alter our other physiological 512 variables (especially shear patterns), we feel that the small change in blood pressure is likely 513 trivial. Although the recovery time between LBNP, control, and LBPP trials (5 minutes) was 514 acute, previous data (18, 43) , and our data indicates that participants research steady state 515 following this short recovery period. Another consideration is that due to methodological 516 constraints at high-altitude, we were unable to measure SNA via microneurography, therefore, 517 the absolute effect of LBNP and LBPP on SNA at high-altitude is unknown. Additionally, it is 518 important to consider that neurovascular transduction may be different at high-altitude compared 519 to sea-level, but this is still under debate as there is evidence that neurovascular transduction is 520 reduced (34), or increased (46), with exposure to hypoxia. We did, however, obtain MSNA 521 recordings in the peroneal nerve at rest in a subset of participants (n=4) at both sea-level and 522 high-altitude. We acknowledge that our MSNA data collected at sea-level and high-altitude were 523 in the radial and peroneal nerves, respectively, but it has been previously demonstrated that 524 MSNA does not differ between these two nerves during mild lower-body negative pressure and 525 are both a reflection of global MSNA (42). Although our MSNA sample size was small, we still detected statistical significance between LBNP and LBPP trials, which were recorded using a 527 within subject design at sea-level.
528
Our experimental design warrants further comment. Our LBNP/LBPP methodological 529 approach to bi-directionally alter SNA proved successful; however, the current study design 530 failed to change brachial artery vascular resistance. We view our study design as a "double-531 edged sword", as it altered SNA largely independently of hemodynamics, yet it was not a potent 532 enough stimulus to alter brachial artery resistance, making it unclear if our study design is 533 appropriate to investigate the effects of SNA on peripheral vascular function. Lastly, menstrual 534 cycle was not taken into consideration for our one female participant, and previous evidence 535 indicates that brachial artery FMD changes throughout the menstrual cycle (25). However, our 536 primary research objective was to look at the within-day comparison of brachial FMD between 537 LBNP, control, and LBPP trials, therefore, the results of these data should not be affected by 538 differences in menstrual cycle between sea-level and high-altitude. Importantly, changes in blood 539 viscosity between sea-level and high-altitude was not taken into account when analyzing brachial 540 artery FMD. However, a reduction in brachial artery FMD was still observed at high-altitude, 541 even though hematocrit, thus shear stress, was likely higher during cuff release.
543
Conclusion 544 We used a novel experimental approach to investigate the relationship between sympathetic 545 nervous activity and endothelial function by using mild lower-body negative pressure and lower-546 body positive pressure at both sea-level and high-altitude. We demonstrated for the first time 547 using a novel, experimental design, that altering sympathetic nervous activity largely 548 independent of hemodynamics (e.g. heart rate, stroke volume, shear stress) had no effect on the pressure within the chamber was altered to one of the following: 1) -10 mmHg (LBNP trial), 765 2) remained unchanged at zero mmHg (control trial), or 3) +10 mmHg (LBPP trial). Once 766 pressure was achieved, and maintained for five-minutes, a brachial artery FMD was performed 767 on the participants left arm. Once the brachial artery FMD measurement was collected, the 768 pressure of the lower-body differential pressure chamber was alleviated and the participant was 769 given a five-minute recovery period. The protocol was then repeated for the remaining two 770 randomized conditions (i.e. LBNP, control, or LBPP). Before each condition, a five-minute quiet 771 resting baseline was endured. altitude (n=14). Panels C and D represent mean data ±SEM for relative FMD during LBNP, 792 control, and LBPP trials at sea-level (n=13) and high-altitude (n=14). These findings 793 demonstrate that LBNP nor LBPP had no effect on brachial artery FMD, despite altering MSNA.
794
The gray line on the figure depicts the average between individuals during each trial. 
